| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.0009 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |